ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
1.570
-0.020 (-1.26%)
Jun 11, 2026, 3:58 PM CET
STO:EXPRS2 Market Cap
STO:EXPRS2 has a market cap or net worth of 5.54 million as of June 11, 2026. Its market cap has decreased by -92.54% in one year.
Market Cap
5.54M
Enterprise Value
-15.06M
Revenue
16.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.57
Market Cap Chart
Since July 29, 2016, STO:EXPRS2's market cap has decreased from 117.71M to 5.54M, a decrease of -95.29%. That is a compound annual growth rate of -26.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 5.61M | -90.00% |
| Dec 30, 2025 | 56.13M | 29.73% |
| Dec 30, 2024 | 43.27M | -60.11% |
| Dec 29, 2023 | 108.46M | -82.55% |
| Dec 30, 2022 | 621.64M | -45.72% |
| Dec 30, 2021 | 1.15B | 280.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spago Nanomedical AB | 72.44M |
| Alzinova AB | 71.20M |
| Pila Pharma AB | 68.52M |
| Modus Therapeutics Holding AB | 58.50M |
| Fluicell AB | 54.12M |
| Magle Chemoswed Holding AB | 48.50M |
| 2cureX AB | 44.08M |
| Guard Therapeutics International AB | 28.03M |